Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

DEFECTIVE DRUGS

Defective Drugs
Parker Waichman Nursing Home Abuse Mobile App

Get our Defective Drugs app for iOS and Android devices.

Your Personal Injury Lawyer - Parker Waichman LLP Android app on Google Play

Just Because a Doctor Prescribes a Drug Doesn’t Mean It’s not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Today, the pharmaceutical industry is producing drugs aimed at just about every ailment known to man, adding years to nearly everyone’s life, if not outright saving them. They also enable us to live a better-quality lifestyle for a much longer period of time.

Regrettably, some of the drugs these companies manufacture can ultimately prove to be defective, as well as dangerous – and even deadly. Sometimes it may take years for the side effects to even emerge – which means that ultimately some drugs on the market may end up doing more harm than good.

Like any other for-profit corporate entity, pharmaceutical companies are motivated, in varying degrees, by profit. Sometimes profits are more important than people. Anyone who reads the newspaper knows this to be a fact. In many a lawsuit, a pharmaceutical company will be charged with having known full well about some harmful side effect tied to its flagship billion-dollar powerhouse drug – in some instances, many years in advance of this fact’s public disclosure. Companies hide clinical evidence that a drug may be defective in order to gain the U.S. Food and Drug Administration (FDA)’s approval, and to not create obstacles to sales.

Prescription drugs with deadly or dangerous side effects are sometimes rushed to market without adequate testing, and often people are injured or die before the FDA can identify these drugs as having dangerous side effects that can far outweigh whatever benefits the marketing group had touted.

When an FDA classification leads to a drug recall and when an injury occurs, a lawsuit is frequently filed; drug recall lawsuits typically fall into a range of categories, including drug injury, product liability or medical malpractice lawsuits against drug companies.

If you or a loved one have been injured as a result of a prescription drug, you may have valuable legal rights. Parker Waichman LLP urges you to contact us by completing the form at right or call us at 1-800-YOURLAWYER (1-800-968-7529).

To view more information involving a specific defective drug, drug recall, or drug lawsuit, please click on one of the links listed below.

If the defective drug you are looking for is not below, please visit our Defective Drugs Archives page for additional articles about defective drug lawsuits that Parker Waichman LLP has defended for our clients.

To view defective drug videos from our attorneys Click Here.

Tags:  

Defective Drugs

Defective Drugs NewsRSS Feed

Xarelto Linked to Serious Internal Bleeding and Blood Clots

Feb 13, 2016
Xarelto (rivaroxaban), one of a newer class of blood thinners, has been linked to serious internal bleeding and blood clots. Blood thinners are...

Fresenius Dialysis Suits Not Barred by FDA Notice Court Hears

Feb 12, 2016
Lawsuits filed over Fresenius' GranuFlo and NaturaLyte dialysis drugs are not barred by a 2012 warning posted by the U.S. Food and Drug...

Multiple Sclerosis Drug Tysabri Can Lead to Potentially Fatal Brain Infection

Jan 29, 2016
The risk of developing a potentially fatal brain infection is higher than previously thought for patients taking the genetically engineered multiple...

Federal Judge Denies Claim of Preemption in Zofran Birth Defect Litigation

Jan 28, 2016
U.S. District Judge F. Dennis Saylor IV has denied GlaxoSmithKline's motion to dismiss all claims in multidistrict litigation alleging that the...

Federal Judge Denies GlaxoSmithKline Motion to Dismiss Zofran Birth Defect Cases under Preemption

Jan 25, 2016
Federal Judge F. Dennis Saylor has denied a motion by drug maker GlaxoSmithKline to dismiss cases alleging that the drug Zofran (ondansetron) caused...

Canadian Health Agency Warns that Anti-rejection Drugs Cause Birth Defects

Jan 19, 2016
Health Canada, Canada's health regulatory agency, warns that the organ anti-rejection drugs CellCept (mycophenolate mofetil) and Myfortic...

FDA Safety Alert- Ma Ying Long Licorice Coughing Liquid Contains Undeclared Morphine

Jan 19, 2016
The Food and Drug Administration (FDA) is warning consumers to avoid Licorice Coughing Liquid, an over-the-counter cough syrup that contains...

Study Shows Widely Used Heartburn Drugs Increase the Risk for Kidney Disease

Jan 18, 2016
A study newly published online in JAMA Internal Medicine indicates that proton pump inhibitors (PPIs)-the widely used heartburn medicines-may...

Children's Cough Syrups Recalled Because of Risk of Overdose

Jan 14, 2016
Perrigo Company of Dublin, Ireland has recalled five batches of children's cough syrups produced under a number of store labels because some packages...

Federal Regulators Warn Against Use of AbbVie's Hepatitis C Drugs

Jan 6, 2016
The U.S. Food and Drug Administration (FDA) recently issued a "Safety Communication" concerning AbbVie's Viekira Pak and Technivie; both are...

Research Study Warns about Adverse Effects of NSAIDs on Ovulation

Jan 4, 2016
A presentation at the 2015 European League Against Rheumatism (EULAR) Annual Congress, researchers warned that nonsteroidal anti-inflammatory drugs...

Kentucky Reaches $39.5 Million Settlement in OxyContin and Risperdal Suits

Dec 31, 2015
Purdue Pharma LP and Johnson & Johnson will pay a combined $39.5 million to settle lawsuits brought by the state of Kentucky over the narcotic...
Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo